Global N-Formyl Peptide Receptor 2 Market Research Report 2024

Global N-Formyl Peptide Receptor 2 Market Research Report 2024

The global N-Formyl Peptide Receptor 2 market size is projected to reach US$ 140.71 million by 2030, from US$ 50.37 million in 2022, at a CAGR of 16.48% during 2024-2030.

North America N-Formyl Peptide Receptor 2 market size is valued at US$ 28.27 million in 2023, while Europe N-Formyl Peptide Receptor 2 is 15.24 million. The proportion of the North America is 56.12% in 2023, while Europe is 27.22%, and it is predicted that Europe proportion will reach 26.50% in 2030, trailing a CAGR of 16.08% through the analysis period. As for the Europe N-Formyl Peptide Receptor 2 landscape, Germany is projected to reach US$ 8.41 million by 2030 trailing a CAGR of 15.84% during 2024-2030.

The classification of N-Formyl Peptide Receptor 2 includes Agonists and Antagonists. In 2023, Agonists accounted for a share of 84.42% in the global N-Formyl Peptide Receptor 2 market. In addition, this product segment is poised to reach US$ 116.54 million by 2030 from US$ 42.52 million in 2023.

N-Formyl Peptide Receptor 2 are mainly used in Pharmaceutical Company, Universities and Research Institutes and Others markets. In N-Formyl Peptide Receptor 2 market, Pharmaceutical Company holds an important share in terms of Application, and it is expected to reach US$ 103.13 million by 2030, at a CAGR of 16.79% during 2024 and 2030.

The N-Formyl Peptide Receptor 2 market competition will be still intense. Bio-Techne, Alomone Labs, Merck, Abcam and MedChemExpress is the leading manufacturer in global N-Formyl Peptide Receptor 2 market. The top 5 listed companies accounted for 45.27% of the market share in 2023 in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for N-Formyl Peptide Receptor 2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding N-Formyl Peptide Receptor 2.

The N-Formyl Peptide Receptor 2 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global N-Formyl Peptide Receptor 2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the N-Formyl Peptide Receptor 2 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Bio-Techne

Abcam

Enzo Life Sciences

MedChemExpress

Anaspec

Merck

Discoverx

BioGems

GenScript Company

Alomone Labs

Segment by Type

Agonists

Antagonists

Segment by Application

Pharmaceutical Company

Universities and Research Institutes

Others

By Region

North America

United States

Canada

Mexico

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Europe

Germany

France

U.K.

Italy

Switzerland

Rest of Europe

South America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of N-Formyl Peptide Receptor 2 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.